Attendance to cervical cancer screening among Roma and non-Roma
women living in North-Western region of Romania
Ofelia S¸ uteu
Received: 22 September 2017 / Revised: 12 April 2018 / Accepted: 19 April 2018 / Published online: 27 April 2018
Ó Swiss School of Public Health (SSPH+) 2018
Objectives Romania has Europe’s highest incidence and mortality rates of cervical cancer. Participation in the national
cervical cancer-screening programme is low, especially among minority Roma women.
Methods We conducted a cross-sectional study, using a structured questionnaire aiming to quantify reasons for screening
attendance among women in North-Western region of Romania.
Results 980 women were enrolled in this study. Data were analysed using logistic regression, estimating odds ratios (OR)
and 95% conﬁdence intervals (CI). This study revealed that Roma women (46%) attended screening less frequently that
non-Roma women (63%),; however, ethnicity in itself was not associated with screening attendance. Instead we found that
attendance to the cervical cancer screening programme was determined by having ever heard about a screening oppor-
tunity (OR 5.90, 95% CI 3.76-9.27) and having three or more sex partners (OR 5.99, 95% CI 1.71–21.04).
Conclusions We concluded that information about the screening programme’s existence and its rationale does not reach the
women targeted for screening sufﬁciently and argue that a process of user involvement aiming to build contact, interaction
and cooperation between the programme and its potential participants is warranted.
Keywords Cervical cancer screening attendance Á Minority Roma women Á Discrimination Á Access to health Á
Health insurance Á Odds ratio
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00038-018-1107-5) contains supplementary
material, which is available to authorized users.
& Trude Andreassen
Cancer Registry of Norway, Institute of Population-Based
Cancer Research, Majorstuen, Post-box 5213, 0304 Oslo,
Institute of Basic Medical Sciences, University of Oslo, Oslo,
The Romanian Cancer Society, Cluj-Napoca, Romania
lsan Research Center, Genetic Epidemiology Group,
Institute of Health and Society, University of Oslo, Oslo,
University of Medicine and Pharmacy, ‘‘Iuliu Hat¸ieganu’’,
Institute of Oncology ‘‘Prof. Dr. Ion Chiricut¸a
(IOCN), Cluj-Napoca, Romania
Department of Preventive Medicine, University of Southern
California, Los Angeles, CA, USA
Department of Community Medicine, Faculty of Health
Sciences, University of Tromsø, The Arctic University of
Norway, Tromsø, Norway
Department of Medical Epidemiology and Biostatistics,
Karolinska Institutet, Stockholm, Sweden
International Journal of Public Health (2018) 63:609–619